These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21718968)

  • 21. Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys.
    Cleeren E; Casteels C; Goffin K; Koole M; Van Laere K; Janssen P; Van Paesschen W
    Epilepsia; 2018 May; 59(5):959-970. PubMed ID: 29663353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin transporter binding after recovery from eating disorders.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Becker C; Ziolko SK; Mathis CA; Wagner A; Barbarich-Marsteller NC; Putnam K; Kaye WH
    Psychopharmacology (Berl); 2007 Dec; 195(3):315-24. PubMed ID: 17690869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain volumetric abnormalities in patients with anorexia and bulimia nervosa: a voxel-based morphometry study.
    Amianto F; Caroppo P; D'Agata F; Spalatro A; Lavagnino L; Caglio M; Righi D; Bergui M; Abbate-Daga G; Rigardetto R; Mortara P; Fassino S
    Psychiatry Res; 2013 Sep; 213(3):210-6. PubMed ID: 23856299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study.
    Monteleone AM; Monteleone P; Esposito F; Prinster A; Volpe U; Cantone E; Pellegrino F; Canna A; Milano W; Aiello M; Di Salle F; Maj M
    J Psychiatr Res; 2017 Jul; 90():94-101. PubMed ID: 28249187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
    Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
    Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: a pilot [(18)F]MPPF/PET study.
    Galusca B; Sigaud T; Costes N; Redoute J; Massoubre C; Estour B
    World J Biol Psychiatry; 2014 Dec; 15(8):599-608. PubMed ID: 25054914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and effective connectivity of anterior insula in anorexia nervosa and bulimia nervosa.
    Kim KR; Ku J; Lee JH; Lee H; Jung YC
    Neurosci Lett; 2012 Jul; 521(2):152-7. PubMed ID: 22684096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered structural and effective connectivity in anorexia and bulimia nervosa in circuits that regulate energy and reward homeostasis.
    Frank GK; Shott ME; Riederer J; Pryor TL
    Transl Psychiatry; 2016 Nov; 6(11):e932. PubMed ID: 27801897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain glucose metabolism in eating disorders assessed by positron emission tomography.
    Delvenne V; Goldman S; De Maertelaer V; Lotstra F
    Int J Eat Disord; 1999 Jan; 25(1):29-37. PubMed ID: 9924650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol awakening response in patients with anorexia nervosa or bulimia nervosa: relationships to sensitivity to reward and sensitivity to punishment.
    Monteleone P; Scognamiglio P; Monteleone AM; Perillo D; Maj M
    Psychol Med; 2014 Sep; 44(12):2653-60. PubMed ID: 25055178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
    Ranganathan M; Cortes-Briones J; Radhakrishnan R; Thurnauer H; Planeta B; Skosnik P; Gao H; Labaree D; Neumeister A; Pittman B; Surti T; Huang Y; Carson RE; D'Souza DC
    Biol Psychiatry; 2016 Jun; 79(12):997-1005. PubMed ID: 26432420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa.
    Monteleone AM; Monteleone P; Serino I; Scognamiglio P; Di Genio M; Maj M
    Int J Eat Disord; 2015 Sep; 48(6):615-21. PubMed ID: 25808182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased cerebral opioid receptors availability related to hormonal and psychometric profile in restrictive-type anorexia nervosa.
    Galusca B; Traverse B; Costes N; Massoubre C; Le Bars D; Estour B; Germain N; Redouté J
    Psychoneuroendocrinology; 2020 Aug; 118():104711. PubMed ID: 32460196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.
    Borgan F; Laurikainen H; Veronese M; Marques TR; Haaparanta-Solin M; Solin O; Dahoun T; Rogdaki M; Salokangas RK; Karukivi M; Di Forti M; Turkheimer F; Hietala J; Howes O;
    JAMA Psychiatry; 2019 Oct; 76(10):1074-1084. PubMed ID: 31268519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resting-state synchrony between anterior cingulate cortex and precuneus relates to body shape concern in anorexia nervosa and bulimia nervosa.
    Lee S; Ran Kim K; Ku J; Lee JH; Namkoong K; Jung YC
    Psychiatry Res; 2014 Jan; 221(1):43-8. PubMed ID: 24300085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [F]MK-9470 PET study.
    Ly HG; Ceccarini J; Weltens N; Bormans G; Van Laere K; Tack J; Van Oudenhove L
    Psychother Psychosom; 2015; 84(3):149-58. PubMed ID: 25833408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [
    Takkinen JS; López-Picón FR; Kirjavainen AK; Pihlaja R; Snellman A; Ishizu T; Löyttyniemi E; Solin O; Rinne JO; Haaparanta-Solin M
    Neurobiol Aging; 2018 Sep; 69():199-208. PubMed ID: 29909177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
    Liu P; Lin LS; Hamill TG; Jewell JP; Lanza TJ; Gibson RE; Krause SM; Ryan C; Eng W; Sanabria S; Tong X; Wang J; Levorse DA; Owens KA; Fong TM; Shen CP; Lao J; Kumar S; Yin W; Payack JF; Springfield SA; Hargreaves R; Burns HD; Goulet MT; Hagmann WK
    J Med Chem; 2007 Jul; 50(15):3427-30. PubMed ID: 17608398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB
    Ceccarini J; Ahmad R; Van de Vliet L; Casteels C; Vandenbulcke M; Vandenberghe W; Van Laere K
    J Nucl Med; 2019 Jan; 60(1):115-121. PubMed ID: 29934407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eating disorders: Do PET and SPECT have a role? A systematic review of the literature.
    Gianni AD; De Donatis D; Valente S; De Ronchi D; Atti AR
    Psychiatry Res Neuroimaging; 2020 Jun; 300():111065. PubMed ID: 32234640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.